Something is coming — and if your plan relies on retrospective chart reviews, you'll want to pay attention.

CMS is proposing a change under PY2027 that could exclude diagnoses from unlinked chart review records in risk score calculations. The projected industry-wide impact? $7.2 billion.

We're putting together a free live webinar to break down what this means for your plan operationally — and what you can do now to assess your exposure.

Drop a comment or follow our page to be notified when registration opens.

📩 Questions already? Reach us at support@healthdatamax.com

#MedicareAdvantage #RiskAdjustment #CMSPY2027 #RAF #HealthDataMax